Healthcare
Soligenix Gains European Orphan Drug Designation for Behçet's Disease Therapy SGX945
The European Commission granted orphan drug designation to Soligenix's SGX945 for treating Behçet's disease, validating the therapy's potential and providing regulatory and commercial incentives for development in a rare disease area with significant unmet need.
Cardio Diagnostics Holdings Leverages AI and Epigenetics for Advanced Cardiovascular Disease Management
Cardio Diagnostics Holdings is advancing cardiovascular disease prevention and detection through an AI-driven platform that integrates genetics and epigenetics to provide personalized insights.
LIXTE Biotechnology's LB-100 Represents Novel Cancer Treatment Approach Through PP2A Inhibition
LIXTE Biotechnology Holdings is advancing LB-100, a first-in-class PP2A inhibitor designed to enhance existing cancer therapies by making tumors more responsive to chemotherapy and immunotherapy in multiple clinical programs targeting solid tumors with significant unmet medical need.
Formycon to Announce 2025 Financial Results and Participate in Key Investor Conferences
Formycon AG will release its 2025 financial results and provide a 2026 outlook during an April conference call, while planning participation in multiple international investor conferences to showcase its biosimilar pipeline amid growing market opportunities.
BioXgen Seeks Crowdfunding Investment for Cardiac Patch Targeting Post-Surgery Complication
BioXgen is launching a Regulation Crowdfunding investment round and hosting a webinar to demonstrate its cardiac patch designed to prevent postoperative atrial fibrillation, a common complication affecting nearly half of open-heart surgery patients.
New Oral Rinse Demonstrates Superior Gingivitis Protection in Saliva Environment
ioRinse Ultra has shown complete elimination of gingivitis-causing bacteria within 30 seconds in saliva-inclusive testing, addressing a critical gap in traditional oral rinse evaluation that could transform daily oral care routines.
Molecular Testing Gains Importance in Complex CNS Cancer Diagnosis and Treatment
Molecular analysis is becoming crucial for identifying and treating complex central nervous system tumors, which traditional methods often miss, with companies like CNS Pharmaceuticals advancing targeted drug development.
NanoViricides Highlights NV-387 as Potential Measles Treatment Amid Global Outbreak Concerns
NanoViricides announced its antiviral drug candidate NV-387 may address the growing global measles outbreak, potentially complementing vaccination efforts by reducing transmission and treating infected patients.
Oncotelic Therapeutics Featured in Editorial on Biotech Valuation Trends
Oncotelic Therapeutics' diversified pipeline and strategic holdings, including a 45% stake in GMP Bio valued at over $1 billion, exemplify how scientific progress and commercialization proximity are increasingly recognized as measurable financial assets under U.S. GAAP, reflecting a broader shift in biotech valuation.
Soligenix CEO Emphasizes Capital Discipline as Key to Biotech Success in Constrained Funding Environment
Soligenix CEO Dr. Christopher J. Schaber highlights capital discipline as essential for biotech companies to navigate today's challenging funding landscape, where strategic resource allocation and milestone-focused development are critical for attracting investment and advancing programs toward commercialization.
Soligenix CEO Advocates for Patient-Centric Drug Reformulation to Improve Treatment Access and Adherence
Soligenix CEO Christopher Schaber argues that reformulating therapies to better align with patients' daily lives can enhance treatment access, adherence, and clinical trial success, reflecting a broader industry shift toward patient-centered drug development.
South Ogden Orthodontic Practice Emphasizes Personalized Care and Advanced Technology
Albrechtsen & Fanelli Orthodontics in South Ogden provides comprehensive orthodontic services using advanced technology and personalized treatment approaches for both children and adults.
Babston Oral Surgery Expands Dental Implant Services in Mobile, Enhancing Patient Access to Permanent Tooth Replacement Solutions
Babston Oral Surgery's expansion of dental implant services in Mobile addresses critical oral health needs by providing permanent tooth replacement options that improve both function and quality of life for patients.
New Book Addresses Mental Health Crisis Through Faith-Based Approach
Dr. Walter Malone Jr.'s new book 'Tailored to Win' offers biblical solutions to rising anxiety and depression rates, providing practical guidance for finding purpose and spiritual strength.
BRYGE AI Wins Silver Stevie Award for Women-Focused Health Technology Innovation
BRYGE AI's recognition at the 2025 Stevie Awards for Women in Business highlights the growing importance of technology solutions addressing communication challenges faced by women with ADHD in professional and personal settings.
CollectionPro Expands Healthcare Claims Recovery Services with New Chicago Hospital Acquisition
CollectionPro's expansion and innovative 'no recovery, no fee' model addresses the growing crisis of underpaid healthcare claims, offering providers automated solutions to navigate complex regulatory environments while improving financial recovery.
Cybin Reports Strong Q2 2025 Results and Advances Late-Stage Neuropsychiatry Programs
Cybin Inc. has reported strong institutional demand in its second-quarter 2025 results while advancing multiple late-stage clinical programs for mental health treatments, positioning the company for key 2026 data readouts that could significantly impact neuropsychiatry treatment options.
Lantern Pharma Reports Strong Q3 2025 Results with AI-Driven Oncology Pipeline Advances
Lantern Pharma demonstrated significant clinical progress in its AI-driven oncology programs, including successful Phase 1a trial results for LP-184 and regulatory clarity for pediatric CNS cancer development, positioning the company to address multiple high-value cancer markets.
NextPlat Corp Reports Q3 2025 Results with Reduced Losses Amid Cost-Cutting Measures
NextPlat Corp's third-quarter results show significant cost reductions and improving healthcare trends despite revenue declines, highlighting the company's progress toward financial stability.
Oragenics Regains NYSE Compliance While Advancing Neurological Therapeutics Pipeline
Oragenics Inc. has regained full NYSE American compliance while making significant progress toward its first clinical trial and expanding its neurological therapeutics pipeline through an AI-driven collaboration with Receptor.AI.
Annovis Bio Advances Alzheimer's Treatment with Phase 3 Trial Progress and Promising Biomarker Data
Annovis Bio reports significant progress in its Phase 3 Alzheimer's trial with full site activation and promising biomarker data showing buntanetap's disease-modifying potential, positioning the company for potential regulatory submission.
Strawberry Fields REIT Reports Strong Q3 2025 Growth Through Strategic Healthcare Property Acquisitions
Strawberry Fields REIT demonstrated significant financial growth in Q3 2025 through strategic acquisitions of healthcare facilities, boosting funds from operations and rental income while expanding its skilled nursing portfolio.
Cybin to Present Neuropsychiatry Pipeline at Jefferies Global Healthcare Conference
Cybin Inc. will present its late-stage neuropsychiatry pipeline including breakthrough-designated depression treatment at the Jefferies Global Healthcare Conference, highlighting the company's progress in developing novel mental health therapies.
HeartBeam Ranked Second Globally in Portable ECG Innovation
HeartBeam has been recognized as a top global innovator in portable ECG technology, ranking second worldwide in 12-lead ECG innovation among 243 companies analyzed, highlighting the company's growing influence in remote cardiac care solutions.
GeoVax Advances Vaccine Programs Amid Global Health Crises Despite Financial Losses
GeoVax Labs reported significant progress in its mpox, COVID-19, and cancer vaccine programs during Q3 2025, positioning the company as a key player in addressing urgent public health needs while navigating financial challenges.
Former NASA Engineer Releases Book on Anxiety Relief Through Energy Therapy
Mark L. Fox, former Space Shuttle Chief Engineer, has published a book promoting PEMF therapy as a drug-free solution for anxiety, chronic pain, and sleep disorders based on two decades of research.
Utah Governor and BioUtah Recognize Co-Diagnostics Following Saudi Arabia Joint Venture
Co-Diagnostics' expansion into Saudi Arabia through a new joint venture demonstrates Utah's growing influence in global life sciences and represents significant international market penetration for local diagnostic technology.
Biohacking Index Report Identifies Top 10 Wellness Brands Driving Verified Innovation
The October 2025 Biohacking Index Report reveals ten high-growth wellness brands leading the industry through data-backed transparency and verified consumer reviews, highlighting a shift toward evidence-based health solutions.
NanoViricides Secures $6 Million in Funding to Advance Antiviral Drug Pipeline
NanoViricides has completed a $6 million capital raise to fund development of its broad-spectrum antiviral drug candidates including NV-387 for respiratory infections and NV-HHV-1 for shingles treatment.
Chiropractor Faces Legal Action After Secretly Filming Nude Patients
A chiropractic patient has retained legal counsel after discovering her trusted doctor secretly recorded her and hundreds of other patients, including minors, while undressed during medical treatments.